Contact Us
  Search
The Business Research Company Logo

Isothermal Nucleic Acid Amplification Technology (INAAT) Market Report 2026

Buy Now
Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Report 2026
Published :January 2026
Pages :150
Format :PDF
Delivery Time :2-3 Business Days
Why 2-3 days? We update the report with the latest data and news before delivery. Let us know if you need us to expedite.
Report Price :$4,490.00

Isothermal Nucleic Acid Amplification Technology (INAAT) Market Report 2026

Global Outlook – By Product (Instrument, Reagent), By Technology (NASBA, Loop-Mediated Isothermal Amplification (LAMP)), By Application (Blood Screening, Infectious Disease Diagnostics), By End-User (Hospital, Reference Laboratories, Other End-Users) - Market Size, Trends, And Global Forecast 2026-2035

Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview

• Isothermal Nucleic Acid Amplification Technology (INAAT) market size has reached to $4.33 billion in 2025 • Expected to grow to $8.57 billion in 2030 at a compound annual growth rate (CAGR) of 14.7% • Growth Driver: Rising Global Incidence Of Infectious And Chronic Diseases Sparks Urgent Need For Isothermal Nucleic Acid Amplification Technology (INAAT) • Market Trend: Increasing Focus On Innovative Solutions To Gain A Competitive Edge In The Market • North America was the largest region in 2025 and Western Europe is the fastest growing region.
Research Expert

Book your 30 minutes free consultation with our research experts

What Is Covered Under Isothermal Nucleic Acid Amplification Technology (INAAT) Market?

Isothermal nucleic acid amplification technology (INAAT) is a technique that amplifies DNA samples. Isothermal nucleic acid amplification technologies are used to amplify DNA sequences from two different nucleic acid segments at a constant temperature. The main product types of isothermal nucleic acid amplification technology are instrument and reagent. A reagent is a material or compound that is added to a system to produce a chemical reaction or to determine whether or not a reaction occurred. The various technologies used are NASBA, and HAD, which are applied for blood screening, infectious disease diagnostics, and cancer. The various end users include hospitals, reference laboratories, and others.
Isothermal Nucleic Acid Amplification Technology (INAAT) Market Global Report 2026 Market Report bar graph

What Is The Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size and Share 2026?

The isothermal nucleic acid amplification technology (inaat) market size has grown rapidly in recent years. It will grow from $4.33 billion in 2025 to $4.95 billion in 2026 at a compound annual growth rate (CAGR) of 14.3%. The growth in the historic period can be attributed to increasing prevalence of infectious diseases, rising demand for rapid diagnostic techniques, limitations of traditional pcr methods, growing use of molecular diagnostics in hospitals, expansion of blood screening programs.

What Is The Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth Forecast?

The isothermal nucleic acid amplification technology (inaat) market size is expected to see rapid growth in the next few years. It will grow to $8.57 billion in 2030 at a compound annual growth rate (CAGR) of 14.7%. The growth in the forecast period can be attributed to growth in decentralized diagnostic testing, rising adoption of portable diagnostic instruments, increasing focus on early disease detection, expanding applications in oncology diagnostics, rising healthcare investments in emerging markets. Major trends in the forecast period include rapid point-of-care molecular testing adoption, growing demand for portable inaat instruments, expansion of isothermal amplification in infectious disease testing, increased use of inaat in blood screening programs, rising preference for fast and low-complexity diagnostic workflows.

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Segmentation

1) By Product: Instrument, Reagent 2) By Technology: NASBA, Loop-Mediated Isothermal Amplification (LAMP) 3) By Application: Blood Screening, Infectious Disease Diagnostics 4) By End-User: Hospital, Reference Laboratories, Other End-Users Subsegments: 1) By Instrument: Portable Instruments, Benchtop Instruments 2) By Reagent: Enzymes, Primers And Probes, Buffers

What Is The Driver Of The Isothermal Nucleic Acid Amplification Technology (INAAT) Market?

The increasing incidence of Infectious and Chronic Diseases is driving the growth of the Isothermal Nucleic Acid Amplification Technology (INAAT) market. The incidence of infectious diseases such as H. influenzae, S. pneumonia (respiratory tract infections), N. gonorrhoeae, C. trachomatis (genital infections), and TB are increasing and require isothermal nucleic acid amplification technology (INAAT) to diagnose them. For instance, in 2023, according to the World Health Organization (WHO), a Switzerland-based health organization, every year, an estimated 10 million people are infected and 1.5 million people die due to tuberculosis, an infectious disease. Increase in infectious or chronic disease drives the growth of the isothermal nucleic acid amplification technology market.

Key Players In The Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market

Major companies operating in the isothermal nucleic acid amplification technology (inaat) market are Abbott Laboratories, bioMérieux SA, Qiagen NV, Becton, Dickinson and Company, Hologic Inc., Quidel Corporation, Thermo Fisher Scientific Inc., New England Biolabs Inc., Lucigen Corporation, BioHelix Corporation, Meridian Bioscience Inc., Ustar Biotechnologies Ltd., Atila Biosystems Incorporated, OptiGene Limited, DiaSorin SpA, Grifols SA, LGC Ltd., Jena Bioscience GmbH, Eiken Chemical Co., Ltd., Canon Medical Systems Corporation, Roche Diagnostics International AG

What Are Latest Mergers And Acquisitions In The Isothermal Nucleic Acid Amplification Technology (INAAT) Market?

In February 2023, Sherlock Biosciences, a US-based biotechnology company, acquired Sense Biodetection for an undisclosed amount. By acquiring Sense, Sherlock aims to enhance its diagnostic capabilities by integrating Sense's LAMP-based technology with its own advanced CRISPR methodologies, thereby improving the speed and accessibility of molecular testing. Sense Biodetection is a UK-based company, specializes in developing rapid, point-of-care diagnostic solutions that leverage isothermal nucleic acid amplification technology methods, particularly Loop-Mediated Isothermal Amplification (LAMP).

Regional Outlook

North America was the largest region in the isothermal nucleic acid amplification technology (INAAT) market in 2025. Western Europe was the second largest region in the isothermal nucleic acid amplification technology (INAAT) market. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Need data on a specific region in this market?

What Defines the Isothermal Nucleic Acid Amplification Technology (INAAT) Market?

The isothermal nucleic acid amplification technology (INAAT) market includes revenues earned by reaction systems and related services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Isothermal Nucleic Acid Amplification Technology (INAAT) Market Report 2026?

The isothermal nucleic acid amplification technology (inaat) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the isothermal nucleic acid amplification technology (inaat) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Isothermal Nucleic Acid Amplification Technology (INAAT) Market Report Forecast Analysis

Report Attribute Details
Market Size Value In 2026$4.95 billion
Revenue Forecast In 2035$8.57 billion
Growth RateCAGR of 14.3% from 2026 to 2035
Base Year For Estimation2025
Actual Estimates/Historical Data2020-2025
Forecast Period2026 - 2030 - 2035
Market RepresentationRevenue in USD Billion and CAGR from 2026 to 2035
Segments CoveredProduct, Technology, Application, End-User
Regional ScopeAsia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country ScopeThe countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies ProfiledAbbott Laboratories, bioMérieux SA, Qiagen NV, Becton, Dickinson and Company, Hologic Inc., Quidel Corporation, Thermo Fisher Scientific Inc., New England Biolabs Inc., Lucigen Corporation, BioHelix Corporation, Meridian Bioscience Inc., Ustar Biotechnologies Ltd., Atila Biosystems Incorporated, OptiGene Limited, DiaSorin SpA, Grifols SA, LGC Ltd., Jena Bioscience GmbH, Eiken Chemical Co., Ltd., Canon Medical Systems Corporation, Roche Diagnostics International AG
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Frequently Asked Questions

The Isothermal Nucleic Acid Amplification Technology (INAAT) market was valued at $4.33 billion in 2025, increased to $4.95 billion in 2026, and is projected to reach $8.57 billion by 2030.
request a sample here
The global Isothermal Nucleic Acid Amplification Technology (INAAT) market is expected to grow at a CAGR of 14.7% from 2026 to 2035 to reach $8.57 billion by 2035.
request a sample here
Some Key Players in the Isothermal Nucleic Acid Amplification Technology (INAAT) market Include, Abbott Laboratories, bioMérieux SA, Qiagen NV, Becton, Dickinson and Company, Hologic Inc., Quidel Corporation, Thermo Fisher Scientific Inc., New England Biolabs Inc., Lucigen Corporation, BioHelix Corporation, Meridian Bioscience Inc., Ustar Biotechnologies Ltd., Atila Biosystems Incorporated, OptiGene Limited, DiaSorin SpA, Grifols SA, LGC Ltd., Jena Bioscience GmbH, Eiken Chemical Co., Ltd., Canon Medical Systems Corporation, Roche Diagnostics International AG .
request a sample here
Major trend in this market includes: Increasing Focus On Innovative Solutions To Gain A Competitive Edge In The Market. For further insights on this market.
request a sample here
North America was the largest region in the isothermal nucleic acid amplification technology (INAAT) market in 2025. Western Europe was the second largest region in the isothermal nucleic acid amplification technology (INAAT) market. The regions covered in the isothermal nucleic acid amplification technology (inaat) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
request a sample here
Research Expert

Book your 30 minutes free consultation with our research experts

Chat with us